What Researchers Did
Researchers followed 44 women who still had symptoms after breast-conserving surgery and radiation, and compared 32 who received hyperbaric oxygen therapy with 12 who received no further treatment.
What They Found
In this prospective study of 44 women with lasting symptoms after breast-conserving therapy, the 32 women who received hyperbaric oxygen therapy had lower pain, edema and erythema scores than 12 untreated controls (p less than 0.001). Treatment was given in a multiplace chamber with 100 percent oxygen at 240 kPa for 90-minute sessions, 5 times per week, for a median of 25 sessions (range 7 to 60). Fibrosis and telangiectasia were not significantly affected. Seven of 32 treated women were free of symptoms afterward, while all 12 controls still had complaints.
What This Means for Canadian Patients
For women with pain, redness or swelling that lasts after breast-conserving surgery and radiation, this study reports lower symptom scores in the group that received hyperbaric oxygen. The authors state that hyperbaric oxygen therapy should be considered as a treatment option for this group. The abstract reports no benefit for fibrosis or telangiectasia, and most treated women (25 of 32) were not symptom-free.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was small, the control group had only 12 women, and the abstract does not say that patients were randomly assigned to treatment or control, so the groups may have differed in ways that affect the results.